TITLE

Formative research to shape HPV vaccine introduction strategies in Peru

AUTHOR(S)
Bartolini, Rosario M.; Drake, Jennifer Kidwell; Creed-Kanashiro, Hilary M.; Díaz-Otoya, Margarita M.; Mosqueira-Lovón, Nelly Rocío; Penny, Mary E.; Winkler, Jennifer L.; LaMontagne, Scott; Bingham, Allison
PUB. DATE
May 2010
SOURCE
Salud Pública de México;may2010, Vol. 52 Issue 3, p226
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objetivo. Comprender el contexto sociocultural, las capacidades del sistema de salud y las condiciones políticas vinculadas al cáncer cervical y a la vacuna contra el VPH para diseñar una estrategia apropiada de introducción de la vacuna contra el VPH. Material y métodos. Investigación formativa usando técnicas cualitativas y cuantitativas. Los participantes incluyeron niños, padres, líderes, funcionarios del sector salud y educación, y diseñadores de políticas. Resultados. Generalmente se apoya la introducción de la vacuna contra el VPH, dado que se aprecian los beneficios de la vacunación y se desea prevenir el cáncer. En la comunidad se encontraron preocupaciones sobre seguridad, confianza y calidad de atención. El sistema de inmunizaciones en el Perú es eficiente y tiene la capacidad para incluir la vacuna contra el VPH. Conclusiones. La investigación formativa permite comprender elementos clave que ayudan a diseñar un programa efectivo para la introducción de la vacuna contra el VPH.
ACCESSION #
51301061

 

Related Articles

  • Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries. Natunen, Kari; Lehtinen, Johannes; Namujju, Proscovia; Sellors, John; Lehtinen, Matti // Infectious Diseases in Obstetrics & Gynecology;2011, Vol. 2011, Special section p1 

    Cervical cancer and other human papillomavirus- (HPV-) related cancers are preventable, but preventive measures implemented in developing countries and especially in low-income rural regions have not been effective. Cervical cancer burden derived from sexually transmitted HPV infections is the...

  • Epidemiology of cervical cancer in Latin America. Capote Negrin, Luis G. // Ecancermedicalscience;2015, Vol. 9 Issue 577-607, p1 

    The basic aspects of the descriptive epidemiology of cervical cancer in Latin America are presented. A decrease in the incidence and mortality rates has been observed in the period from 2000 to 2012 in all countries across the region, this has not occurred at the same proportions, and in many...

  • Genetic Variability in L1 and L2 Genes of HPV-16 and HPV-58 in Southwest China. Yaofei Yue; Hongying Yang; Kun Wu; Lijuan Yang; Junying Chen; Xinwei Huang; Yue Pan; Youqing Ruan; Yujiao Zhao; Xinan Shi; Qiangming Sun; Qihan Li // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    HPV account for most of the incidence of cervical cancer. Approximately 90% of anal cancers and a smaller subset (<50%) of other cancers (oropharyngeal, penile, vaginal, vulvar) are also attributed to HPV. The L1 protein comprising HPV vaccine formulations elicits high-titre neutralizing...

  • Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Brotherton, Julia M. L.; Kaldor, John M.; Garland, Suzanne M. // Sexual Health (14485028);Sep2010, Vol. 7 Issue 3, p310 

    The article provides information on a study which proposed a possible multifaceted strategy to human papillomavirus (HPV) related surveillance in Australia following the adoption of a national HPV vaccination program. Main components discussed in detail are monitoring of vaccine coverage,...

  • DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studies. Kyusun Torque Han; Jeong-Im Sin // Clinical & Experimental Vaccine Research;Jul2013, Vol. 2 Issue 2, p106 

    Human papillomavirus (HPV) infection is a major cause of cervical cancer and its precancerous diseases. Cervical cancer is the second deadliest cancer killer among women worldwide. Moreover, HPV is also known to be a causative agent of oral, pharyngeal, anal and genital cancer. Recent...

  • Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women. Pitts, Marian K.; Heywood, Wendy; Ryall, Richard; Smith, Anthony M.; Shelley, Julia M.; Richters, Juliet; Simpson, Judy M. // Sexual Health (14485028);Sep2010, Vol. 7 Issue 3, p299 

    The article presents information on a study which investigated human papillomavirus (HPV) knowledge following the introduction of a national HPV vaccination program in Australia using a representational sample of men and women. Data collection was through computer-assisted telephone interview...

  • Knowledge of Health Care Providers on HPV Related Issues in Cervical Cancer. HUSSAIN, F.; FLORA, M. S.; NAHAR, K.; KHAN, M. // Journal of Bangladesh College of Physicians & Surgeons;Oct2011, Vol. 29 Issue 4, p213 

    Background: The field of cervical cancer prevention is rapidly evolving because of identification of Human Papilloma Virus (HPV) as the necessary cause of disease. HPV vaccines are now in the market.For successful triggering of cervical cancer prevention program, HPV informations should be...

  • HPV VACCINE COULD ALSO PREVENT OROPHARYNGEAL CANCER, SAYS IARC.  // Central European Journal of Public Health;Sep2013, Vol. 21 Issue 3, p149 

    The article presents the result of a study on human papillomavirus (HPV) conducted by the International Agency for Research on Cancer (IARC) and researchers from Costa Rica and the U.S. National Cancer Institute (NCI) in 2004 and 2005. The researchers concluded that the vaccines used in the...

  • Recent trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel. Bassal, Ravit; Schejter, Eduardo; Bachar, Rachel; Shapira, Hagit; Kaufman, Zalman; Cohen, Dani; Keinan-Boker, Lital // Archives of Gynecology & Obstetrics;Aug2015, Vol. 292 Issue 2, p405 

    Purpose: This study describes time trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel in the years 1986-2010 and characterizes these patients by demographics. Methods: A retrospective survey based on cervical cancer and CIN3 data documented in the computerized...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics